InterCure to Participate in A.G.P.’s Spring Consumer Cannabis Conference

InterCure (NASDAQ: INCR) has announced that its CEO, Alexander Rabinovitch, will participate in the Alliance Global Partners Spring Consumer Cannabis Conference on May 3, 2022.

Rhea-AI Summary

InterCure (NASDAQ: INCR) has announced that its CEO, Alexander Rabinovitch, will participate in the Alliance Global Partners Spring Consumer Cannabis Conference on May 3, 2022. As a leading cannabis company outside North America, InterCure, through its wholly owned subsidiary Canndoc, is Israel's largest licensed cannabis producer. The company focuses on manufacturing pharmaceutical-grade medical cannabis products and utilizes a high-margin, vertically integrated model, positioning it as a significant player in the global cannabis market.

Argus Session date unavailable

+1.25% session move Open Argus

Details

News Market Reaction – INCR

The recorded move for INCR in the trading session of this news was +1.25%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK and TORONTO and HERZLIYA, Israel, May 03, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will participate in Alliance Global Partners Spring Consumer Cannabis Conference, taking place May 3, 2022.

About InterCure (dba Canndoc)

InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America.

For more information, visit: http://www.intercure.co.

Contact:

InterCure Ltd.
Amos Cohen, Chief Financial Officer
amos@intercure.co

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What event is InterCure's CEO participating in on May 3, 2022?

InterCure's CEO, Alexander Rabinovitch, will participate in the Alliance Global Partners Spring Consumer Cannabis Conference on May 3, 2022.

What is InterCure known for in the cannabis industry?

InterCure is recognized as the leading, profitable cannabis company outside North America and Israel's largest licensed cannabis producer through its subsidiary Canndoc.

What products does InterCure offer?

InterCure offers Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

What trading symbols represent InterCure?

InterCure trades under NASDAQ: INCR, TSX: INCR.U, and TASE: INCR.

How does InterCure operate in the cannabis market?

InterCure operates using a high-margin, vertically integrated 'seed-to-sale' model, leveraging its market-leading distribution network and international partnerships.